… management of head and neck squamous cell carcinoma (HNSCC), but limited data exist
for comparing these approaches. Using Veterans Health Affairs data, this study compared the …

Purpose: The purpose of this study is to describe the epidemiological profile, histopathological
features, and outcomes of patients diagnosed with renal cell carcinoma (RCC) in a …

… In 2012, there were 49,229 veterans with basal cell carcinoma, 26,310 veterans with
squamous cell carcinoma, and 8,050 veterans with unspecified invasive KC. There were also …

Available descriptive statistics for patients with metastatic basal cell carcinoma (mBCC) are
limited. To describe disease characteristics, treatment patterns, survival outcomes, and …

… of targeted therapies for the treatment of advanced renal cell carcinoma (RCC) and overall
survival (OS) among patients in clinical practice in the Veterans Health Administration (VHA). …

… Persistence and compliance with pazopanib in patients with advanced renal cell
carcinoma within a US administrative claims database. J Manag Care Spec Pharm.2014;20(6):603-10. …

… Nonmelanoma skin cancers were defined as those with final histopathologic diagnoses of
basal cell carcinoma or squamous cell carcinoma (including squamous cell carcinoma in situ). …

e20625 Background: Metastatic basal cell carcinoma (mBCC) is a poorly characterized
condition. Because it is rare, there are limited studies available on patient and disease …

… basal cell carcinoma (BCC) by studying highrisk veterans enrolled in the Veterans Affairs
Keratinocyte Carcinoma … We compared costs to the health care system and benefits of treating …

Objective: To investigate the accuracy of Medical Benefit Schedule (MBS) item numbers to
identify treatments for basal cell carcinomas (BCC) and squamous cell carcinomas (SCC). …